Actively Recruiting
The Cancer Stage Shifting Initiative: Registry and Biorepository to Research and Address Health Disparities in Cancer Care
Led by National Minority Quality Forum · Updated on 2026-04-08
100000
Participants Needed
2
Research Sites
729 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The goal of this observational study is to establish a patient registry and a biorepository (sample collection and storage) to investigate health disparities, access, and barriers to cancer screening and early detection technologies. The registry and biorepository will serve as a resource to support Cancer Early Detection (CED) screenings and future research focused on communities at increased risk for cancer. The study seeks to address: •Barriers and disparities in cancer prevention, screening, and treatment, particularly in historically underrepresented populations. Participants will: * Attend a minimum of five clinic visits over a five-year period for scheduled annual assessments while actively enrolled in the study. * Complete questionnaires at each visit that collect information on their medical history, cancer history, and family cancer history. * Allow relevant health information from their electronic health records (EHR) to be collected and reviewed. * Provide blood, saliva, and stool samples for research purposes. * Enter a long-term follow-up period for an additional five years.
CONDITIONS
Official Title
The Cancer Stage Shifting Initiative: Registry and Biorepository to Research and Address Health Disparities in Cancer Care
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adults 35 years and older.
- Provide written informed consent before any study procedures.
- Understand the study's purpose and procedures.
- Agree that demographic data, medical history, and social health determinants collected can be used for research.
- Agree to release and review of electronic medical records.
- Agree to be followed for the study duration.
- Able to provide up to 100 mLs of whole blood at screening and interim visits.
- Healthy, nonpregnant adult.
- Weigh at least 110 pounds.
- Have negative viral test results.
You will not qualify if you...
- Any medical or mental condition preventing informed consent.
- Unable to understand the study protocol or give informed consent.
- Under 35 years of age at enrollment.
- Women of childbearing age who may be or plan to become pregnant during the study.
- Weigh under 110 pounds.
- Unable to provide biospecimen samples as judged by the investigator.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
Life in 3D Health Services
Flint, Michigan, United States, 48507
Actively Recruiting
2
Grace Clinic
Houston, Texas, United States, 77026
Actively Recruiting
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here